ImmunoPrecise Antibodies Ltd (IPA)

ImmunoPrecise Antibodies Ltd Borsa (IPA) Ultime notizie

Should ImmunoPrecise Antibodies (CVE:IPA) Be Disappointed With Their 23% Profit? - Yahoo Lifestyle UK

Yahoo Lifestyle UK

ImmunoPrecise Antibodies And InterSystems Partner To Leverage AI In Life Sciences, Transforming Patient Care With ... - AccessWire

AccessWire

InterSystems and IPA's Subsidiary BioStrand Collaborate to Unveil the Innovative Integration of Vector Search with ... - Yahoo Finance

Yahoo Finance

IPA Enhances Drug Discovery with Carterra LSA - TipRanks.com - TipRanks

TipRanks

IPA Boosts AI Drug Discovery with Strategic Acquisition - TipRanks.com - TipRanks

TipRanks

ImmunoPrecise Antibodies Ltd. (NASDAQ:IPA) Q3 2024 Earnings Call Transcript - Yahoo Finance

Yahoo Finance

ImmunoPrecise Antibodies Ltd. (IPA) Reports Q3 Loss, Tops Revenue Estimates

Zacks Investment Research

IPA Continues Growth Streak, Slashes Cash Burn - TipRanks.com - TipRanks

TipRanks

IPA Reports Financial Results and Recent Business Highlights for Third Quarter Fiscal Year 2024* - Business Wire

Business Wire

ImmunoPrecise Antibodies (NASDAQ:IPA) Subsidiary BioStrand Introduces Breakthrough AI Model In Life Sciences ... - AccessWire

AccessWire

Why HighPeak Energy Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Thursday's Mid-Day Session

Benzinga

IPA's subsidiary BioStrand Unveils Major Breakthrough in Life Sciences with Advanced Foundation AI Model Utilizing ... - Business Wire

Business Wire

IPA to Unveil Q3 Financials and Business Updates - TipRanks.com - TipRanks

TipRanks

IPA to Report Financial Results and Recent Business Highlights for Third Quarter Fiscal Year 2024 on March 14, 2024 - Business Wire

Business Wire

New Strong Buy Stocks for February 7th

Zacks Investment Research

New Strong Buy Stocks for February 7th - Yahoo Finance

Yahoo Finance

New Strong Buy Stocks for February 5th

Zacks Investment Research

IPA Reports Financial Results and Recent Business Highlights for Second Quarter Fiscal Year 2024* - Business Wire

Business Wire

IPA Announces Closing of $1.265 Million Public Offering of Common Shares - Business Wire

Business Wire

Gold Moves Higher; Campbell Soup Earnings Top Expectations

Benzinga

Why AeroVironment Shares Are Trading Lower By Over 9%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session

Benzinga

Crude Oil Down 4%; Pharvaris Shares Spike Higher

Benzinga

US Stocks Higher; Private Payrolls Rise By 103,000 In November

Benzinga

Why SentinelOne Shares Are Trading Higher By Over 18%; Here Are 20 Stocks Moving Premarket

Benzinga

US Stocks Higher; Private Payrolls Rise By 103,000 In November - MicroAlgo (NASDAQ:MLGO), ImmunoPrecise A - Benzinga

Benzinga

Phreesia (PHR) Reports Q3 Loss, Tops Revenue Estimates

Zacks Investment Research

Current CFO of ImmunoPrecise Antibodies Brad McConn Resigns - CEOWORLD magazine

CEOWORLD magazine

IPA Reports Financial Results and Recent Business Highlights for First Quarter Fiscal Year 2024 - Business Wire

Business Wire

IPA Releases New HYFT-Powered In Silico Humanization Platform, Aims to Disrupt the Transgenic Animal Model Market - BioSpace

BioSpace

ImmunoPrecise's Subsidiary Talem Enters into Exclusive Research Collaboration and License Option Agreement with ... - Business Wire

Business Wire

Talem and Libera Bio partner for discovery of AI-driven antibodies - Pharmaceutical Technology

Pharmaceutical Technology

ImmunoPrecise Antibodies' Subsidiary Talem Therapeutics Announces a Multi-Target AI-Driven Antibody Discovery ... - Business Wire

Business Wire

IPA's Subsidiary BioStrand and BriaCell Announce Artificial Intelligence Collaboration and License Agreement to ... - Business Wire

Business Wire

ImmunoPrecise Antibodies Ltd. Announces Voluntary Delisting from TSX Venture Exchange - Business Wire

Business Wire

IPA Reports Financial Results and Recent Business Highlights for First Quarter Fiscal Year 2023 - Business Wire

Business Wire

IPA Completes Acquisition of Belgian Technology Companies BioStrand, BioKey, and BioClue – Adding Artificial ... - Business Wire

Business Wire

IPA Announces Agreement to Acquire BioStrand BV – Revolutionizing Biotherapeutics with Methodology to Encode ... - Business Wire

Business Wire

IPA Updates on Investigational New Drug (IND) Enabling Program for PolyTope® TATX-03 - Business Wire

Business Wire

Paul Andreola: ImmunoPrecise & Stock Picking In The Small Cap Arena – The Daily Dive - The Deep Dive

The Deep Dive

ImmunoPrecise Antibodies (IPA) Stock Price, News & Analysis - MarketBeat

MarketBeat

IPA Stock Price and Chart — NASDAQ:IPA — TradingView - TradingView

TradingView

ImmunoPrecise Antibodies names Yasmina Noubia Abdiche as chief scientific officer - Proactive Investors USA

Proactive Investors USA

ImmunoPrecise Launches Coronavirus Vaccine and Therapeutic Antibody Program - PR Newswire

PR Newswire

Talem Therapeutics accesses the OmniAb® platform from Ligand Pharmaceuticals - PR Newswire

PR Newswire

ImmunoPrecise guarantees success rate of its B cell Select Antibody Discovery Platform - Proactive Investors UK

Proactive Investors UK

ImmunoPrecise Antibodies on an aggressive sales and business development drive - Proactive Investors UK

Proactive Investors UK

ImmunoPrecise Antibodies collaborates with FIND to advance new tuberculosis diagnostic test - Proactive Investors UK

Proactive Investors UK